April 27th, 2021 No. ACC/HO 008/64 Topic: Management Discussion and Analysis for the Quarter of 1/2021 To: President The Stock Exchange of Thailand During the first quarter of 2021 a new wave of
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
-9320 1 Ref: PCL 2020/018 November 14, 2020 Subject: Management Discussion and Analysis for the 9-month period ended 30 September 2020 To: The President of the Stock Exchange of Thailand Panjawattana
MDA Q3_2019 (Eng ) November 8, 2019 Subject : Interim Management Discussion and Analysis of Q3/2019 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements
ฟอร์ม แบบ RLA (Risk Level Assessment) [รอบที่ 2 ปี 2566] แบบรายงาน/แบบฟอร์ม __คำอธิบายประกอบการจัดทำแบบ RLA [รอบที่ 2 ปี 2566] แบบรายงาน/แบบฟอร์ม แบบรายงานผลการตรวจสอบด้านเทคโนโลยีสารสนเทศและแผนการ
(Translation) No. IR/2561/010 27 February 2018 Subject: Acquisition of assets To: President The Stock Exchange of Thailand Enclosures: Information Memorandum of Singha Estate Public Company Limited
: pato1@cscoms.com August 11, 2017 President The Stock Exchange of Thailand The consolidated financial statement of Pato Chemical Industry Plc. and its subsidiary for Q2 ended June 30, 2017 operational
June 30, 2019 To The President The Stock Exchange of Thailand Management’s Discussion and Analysis Consolidated Financial Statements For six months ended June 30, 2019 Overall Group Performance Table 1
Microsoft Word - I-!9%*#8˙I-*ˇ@( Blue Sky 20200929 EN_MDA Quarterly - Translation - 1 ACC-O-2010004 October 1, 2020 To: President The Stock Exchange of Thailand Subject: Management Discussion and